欧洲神经肿瘤协会(EANO)成人星形细胞及少突胶质细胞胶质瘤诊疗指南
欧洲神经肿瘤协会基于2016年WHO中枢神经系统肿瘤分类及2014年指南后的科学进展,为成人星形细胞及少突胶质细胞胶质瘤(含胶质母细胞瘤)提供病理与影像诊断、手术、放疗和药物治疗推荐,整合了改变临床实践的当代临床试验结果,旨在指导诊疗决策并限制不必要的治疗和费用。
要点
- 指南基于2016年WHO中枢神经系统肿瘤分类制定。
- 推荐聚焦病理与影像诊断及手术、放疗、药物治疗。
- 整合了改变临床实践的当代临床试验结果。
核心结论
- 指南为成人星形细胞及少突胶质细胞胶质瘤(含胶质母细胞瘤)的诊疗决策提供指导,同时限制不必要的治疗和费用。
研究设计与样本
- 欧洲神经肿瘤协会(EANO)制定的指南,基于2016年WHO中枢神经系统肿瘤分类及2014年指南后的科学进展。
关键数值与推荐
- 推荐聚焦病理和影像诊断,以及手术、放疗和药物治疗等主要治疗方式。
- 指南整合了改变临床实践的当代临床试验结果。
临床怎么用
- 指南是欧洲参与胶质瘤患者管理的专业人员、患者及照护者以及医疗保健提供者的资源。
- 指南的实施需要多学科诊疗结构和明确的诊断与治疗流程。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The European Association for Neuro-Oncology guideline provides recommendations for the clinical care of adult patients with astrocytic and oligodendroglial gliomas, including glioblastomas. The guideline is based on the 2016 WHO classification of tumours of the central nervous system and on scientific developments since the 2014 guideline. The recommendations focus on pathological and radiological diagnostics, and the main treatment modalities of surgery, radiotherapy, and pharmacotherapy. In this guideline we have also integrated the results from contemporary clinical trials that have changed clinical practice. The guideline aims to provide guidance for diagnostic and management decisions, while limiting unnecessary treatments and costs. The recommendations are a resource for professionals involved in the management of patients with glioma, for patients and caregivers, and for health-care providers in Europe. The implementation of this guideline requires multidisciplinary structures of care, and defined processes of diagnosis and treatment.
引用
- Weller M, van den Bent M, Tonn JC, et al. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Lancet Oncol. 2017. PMID: 28483413. doi:10.1016/S1470-2045(17)30194-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。